Source:http://linkedlifedata.com/resource/pubmed/id/11948455
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-4-11
|
| pubmed:abstractText |
Selectin ligands are crucial components in the interaction between endothelial cells and extravasating cancer cells and, thus, play an important role in metastasis formation. Head-and-neck squamous cell carcinoma (HNSCC) variants expressing high levels of E48, a human Ly-6 protein (E48(hi)), expressed higher levels of the fucose-generating FX enzyme and of the fucosylated E-selectin ligand sLe(a) than cells expressing low levels of E48 (E48(lo)). Signaling through E48 upregulated expression levels of these molecules in HNSCC. In this work, we provide further evidence supporting the E48-FX-sLe(a) link by showing that FX antisense oligonucleotides reduced sLe(a) expression levels in HNSCC. We also show that E48 may be causally involved in regulating expression levels in HNSCC of 2 additional enzymes involved in the biosynthesis of sLe(a), namely, ST-30 and FucTIII. Also, selectin-mediated adhesion of E48(hi) variants to activated HUVECs was significantly higher than that of E48(lo) variants. Transfection experiments utilizing sense or antisense E48 cDNA indicated that E48 may be causally involved in this adhesion. Chemokines are involved in the extravasation process of tumor cells. The release of chemoattractants from HNSCC variants differing in E48 expression was therefore analyzed. HNSCC did not release any chemoattractants but induced the release of such factors from HUVECs. Supernatants from E48(hi) variants were significantly more efficient than E48(lo) cells at inducing the release of chemoattractants from HUVECs. Transfection experiments indicated that E48 may be causally involved in the induction of chemoattractant release from HUVECs. Angiogenesis is an important manifestation of cancer-endothelium interactions. We therefore assayed for the presence of angiogenic factors in culture supernatants of HNSCC. Supernatants from E48(lo) variants contained significantly higher amounts of PDGF than E48(hi) cells. Transfection experiments indicated that E48 may be causally involved. Taken together, our results suggest that E48 controls important interaction parameters between HNSCC and endothelial cells.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-keto-1,2,3,4-tetrahydrophenanthren...,
http://linkedlifedata.com/resource/pubmed/chemical/3-galactosyl-N-acetylglucosaminide...,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Ly,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Fucosyltransferases,
http://linkedlifedata.com/resource/pubmed/chemical/GPI-Linked Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Gelatinases,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/LY6D protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, Antisense,
http://linkedlifedata.com/resource/pubmed/chemical/Phenanthrenes,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet-Derived Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Selectins,
http://linkedlifedata.com/resource/pubmed/chemical/platelet-derived growth factor BB
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0020-7136
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002 Wiley-Liss, Inc.
|
| pubmed:issnType |
Print
|
| pubmed:day |
20
|
| pubmed:volume |
98
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
803-10
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:11948455-Antigens, Ly,
pubmed-meshheading:11948455-Carcinoma, Squamous Cell,
pubmed-meshheading:11948455-Cell Adhesion,
pubmed-meshheading:11948455-Cell Adhesion Molecules,
pubmed-meshheading:11948455-Cell Movement,
pubmed-meshheading:11948455-Cytokines,
pubmed-meshheading:11948455-DNA Primers,
pubmed-meshheading:11948455-Endothelium, Vascular,
pubmed-meshheading:11948455-Flow Cytometry,
pubmed-meshheading:11948455-Fucosyltransferases,
pubmed-meshheading:11948455-GPI-Linked Proteins,
pubmed-meshheading:11948455-Gelatinases,
pubmed-meshheading:11948455-Glycoproteins,
pubmed-meshheading:11948455-Head and Neck Neoplasms,
pubmed-meshheading:11948455-Humans,
pubmed-meshheading:11948455-Mutagenesis, Site-Directed,
pubmed-meshheading:11948455-Oligonucleotides, Antisense,
pubmed-meshheading:11948455-Phenanthrenes,
pubmed-meshheading:11948455-Platelet-Derived Growth Factor,
pubmed-meshheading:11948455-RNA, Messenger,
pubmed-meshheading:11948455-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11948455-Selectins
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells.
|
| pubmed:affiliation |
Department of Cell Research and Immunology and Ela Kodesz Institute for Research on Cancer Development and Prevention, Tel Aviv University, Tel Aviv, Israel.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|